Date: May 27, 2026
Board Meeting Outcomes
- The company has dispatched letters providing web-link access to the Integrated Annual Report for FY 2025-26 to shareholders who have not registered their email addresses with the Registrar & Share Transfer Agent (RTA) or Depository Participants (DPs).
- The 50th Annual General Meeting is scheduled for Wednesday, June 17, 2026 at 3:00 PM IST through Video Conference/Other Audio-Visual Means.
Other Operational / Legal / Strategic Disclosures
- The disclosure is made under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
- Compliance with Regulation 36(1)(b) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for dissemination of annual report.
- Shareholders are requested to update their email addresses with RTA/DPs to ensure easy access to company documents.
Web Links Provided
- AGM Notice: https://jbpharma.com/download/agm-notice-fy-2025-26-2/?wpdmdl=11211&refresh=6a140b8680cbb1779698566
- Integrated Annual Report: https://jbpharma.com/download/fy-26-annual-report/?wpdmdl=11209&refresh=6a140a6dedd941779698285